title: Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.
authors.forename: Florence
authors.initials: F
authors.lastname: Damond
authors.forename: Sylvie
authors.initials: S
authors.lastname: Lariven
authors.forename: Benedicte
authors.initials: B
authors.lastname: Roquebert
authors.forename: Sylvia
authors.initials: S
authors.lastname: Males
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Genevieve
authors.initials: G
authors.lastname: Morau
authors.forename: Daniel
authors.initials: D
authors.lastname: Toledano
authors.forename: Diane
authors.initials: D
authors.lastname: Descamps
authors.forename: Francoise
authors.initials: F
authors.lastname: Brun-Vezinet
authors.forename: Sophie
authors.initials: S
authors.lastname: Matheron
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015498:HIV-2; D006801:Humans; D019429:Integrase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019562:Viral Load
chemical_list: D019429:Integrase Inhibitors